1. Home
  2. GSK vs BNS Comparison

GSK vs BNS Comparison

Compare GSK & BNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSK
  • BNS
  • Stock Information
  • Founded
  • GSK 1715
  • BNS 1832
  • Country
  • GSK United Kingdom
  • BNS Canada
  • Employees
  • GSK N/A
  • BNS N/A
  • Industry
  • GSK Biotechnology: Pharmaceutical Preparations
  • BNS
  • Sector
  • GSK Health Care
  • BNS
  • Exchange
  • GSK Nasdaq
  • BNS Nasdaq
  • Market Cap
  • GSK 77.4B
  • BNS 68.3B
  • IPO Year
  • GSK N/A
  • BNS N/A
  • Fundamental
  • Price
  • GSK $37.00
  • BNS $56.32
  • Analyst Decision
  • GSK Hold
  • BNS Hold
  • Analyst Count
  • GSK 2
  • BNS 2
  • Target Price
  • GSK N/A
  • BNS $77.50
  • AVG Volume (30 Days)
  • GSK 5.4M
  • BNS 2.4M
  • Earning Date
  • GSK 07-30-2025
  • BNS 08-26-2025
  • Dividend Yield
  • GSK 4.27%
  • BNS 5.44%
  • EPS Growth
  • GSK N/A
  • BNS N/A
  • EPS
  • GSK 0.98
  • BNS 3.46
  • Revenue
  • GSK $40,735,668,430.00
  • BNS $21,114,182,735.00
  • Revenue This Year
  • GSK $6.70
  • BNS $26.09
  • Revenue Next Year
  • GSK $5.42
  • BNS $4.14
  • P/E Ratio
  • GSK $18.05
  • BNS $16.31
  • Revenue Growth
  • GSK 2.57
  • BNS N/A
  • 52 Week Low
  • GSK $31.72
  • BNS $43.68
  • 52 Week High
  • GSK $44.67
  • BNS $57.07
  • Technical
  • Relative Strength Index (RSI)
  • GSK 41.11
  • BNS 68.46
  • Support Level
  • GSK $35.45
  • BNS $54.32
  • Resistance Level
  • GSK $38.97
  • BNS $55.34
  • Average True Range (ATR)
  • GSK 0.80
  • BNS 0.47
  • MACD
  • GSK -0.21
  • BNS -0.02
  • Stochastic Oscillator
  • GSK 33.15
  • BNS 98.54

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About BNS Bank Nova Scotia Halifax Pfd 3

Bank of Nova Scotia is a global financial services provider with over CAD 1.4 trillion in assets. The bank has four major business segments: Canadian banking, international banking, global wealth management, and global banking and markets. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in the Latin America region.

Share on Social Networks: